Listen to Blood & Cancer podcast

Biosimilars with Dr. Gary Lyman	Blood & Cancer	32:06
Advanced bladder cancer: Dr. Arjun Balar talks treatment strategies in a changing field	Blood & Cancer	27:25
Gene therapies in hemophilia with Dr. Glenn Pierce	Blood & Cancer	24:10
Thrombosis and thrombocytopenia caused by COVID-19 vaccines: How to identify and treat VITT, VIPIT, or TTS	Blood & Cancer	23:11
Toward more personalized treatment in prostate cancer: The CCR score predicts metastasis and guides treatment decisions after radiation	Blood & Cancer	28:23
Changing perspectives: Dr. Michael Weiner recounts his experiences as an oncologist who became a cancer patient and then a caregiver	Blood & Cancer	25:28
Optimizing CAR T-cell therapies in lymphoma: Improving response, fighting cytokine release syndrome, and identifying mechanisms of resistance	Blood & Cancer	25:38
Trends in genetic testing for breast and ovarian cancer: Undertesting and racial/ethnic disparities persist	Blood & Cancer	26:43
Improving cancer screening in the COVID era: Drive By Flu-FIT allows for socially distanced colorectal cancer screening	Blood & Cancer	25:00
Unpacking von Willebrand disease guidelines: Dr. Paula James talks diagnosis and pre-procedure prophylaxis	Blood & Cancer	18:39
FDA approvals in hematology and oncology, Part II: New oral formulations, RET and MET inhibitors, and CAR T-cell therapies	Blood & Cancer	20:16
How I treat CLL and MCL: From ‘watch and wait’ to BCL2 and BTK inhibitors, CAR T-cell therapy, and transplant	Blood & Cancer	22:51
COVID-19 vaccination in cancer patients: Who should be vaccinated and when?	Blood & Cancer	30:40
Managing pain in sickle cell crisis with Dr. Ifeyinwa Osunkwo	Blood & Cancer	26:05
FDA approvals in hematology and oncology: Novel agents and new tricks for old drugs	Blood & Cancer	23:25
NCI-MATCH trial reveals actionable mutations and matches cancer patients to targeted therapies	Blood & Cancer	20:08
COVID-19 vaccine 101: Dr. Drew Weissman discusses mechanisms, efficacy, and vaccinating patients with cancer or HIV	Blood & Cancer	23:45
Barriers to clinical trial enrollment for patients with gynecologic cancers: Why patients don’t participate and how to improve enrollment	Blood & Cancer	21:38
Convalescent plasma for COVID-19, race linked to cancer-associated thrombosis risk, iron deficiency common in pregnancy, and more from ‘Best of ASH’	Blood & Cancer	18:59
Thrombosis research from ASH 2020: Khorana score falls short in cancer study, factors predict VTE in cancer patients with COVID-19, and antithrombotics don’t affect severe COVID outcomes	Blood & Cancer	24:31
Highlights from SABCS 2020: New data on CDK4/6 inhibitors, omitting chemotherapy and radiotherapy, underreporting toxicity, and predicting outcomes in breast cancer	Blood & Cancer	52:13
Best of Blood & Cancer 2020	Blood & Cancer	40:24
SABCS 2020: More women may forgo chemo, surgery's role in opioid use, and pregnancy after breast cancer	Blood & Cancer	07:53
How does COVID-19 affect patients with hematologic malignancies? The ASH registry provides some answers	Blood & Cancer	26:33
News from ASH 2020: 'Practice-changing' results with ruxolitinib in chronic GVHD and no benefit seen with tranexamic acid in patients with blood cancers and severe thrombocytopenia	Blood & Cancer	09:41
How I treat GVHD: Dr. James Ferrara explains how biomarkers can predict outcomes and guide the treatment of acute GVHD	Blood & Cancer	28:22
Black patients with ES-SCLC get less chemo, CTCs may guide breast cancer treatment, and new FDA approvals for neuroblastoma and prostate cancer	Blood & Cancer	08:33
Can aerosolized chemotherapy better treat peritoneal carcinomatosis in patients with gynecologic or gastrointestinal cancers?	Blood & Cancer	22:00
News \| Checkpoint inhibitors and COVID-19 mortality; HCC rates slow in cities, continue to climb in rural areas	Blood & Cancer	08:46
Journal highlights with Dr. David Henry: Managing hematologic conditions in pregnancy, combo for elderly AML, genomics in DLBCL, and COVID-19 updates	Blood & Cancer	11:19
Cancer and hepatitis B virus: ASCO's recommendations for HBV screening, monitoring for reactivation, and how to treat patients	Blood & Cancer	23:00
How to kill a trial	Blood & Cancer	07:10
Post-HSCT care at home: Can maintaining the patient’s microbiome prevent GVHD, improve other outcomes, decrease costs, and reduce the risk of COVID-19?	Blood & Cancer	28:07
Real-world checkpoint inhibitor results not as good as trial results	Blood & Cancer	09:09
How I treat NSCLC in the era of checkpoint inhibitors and the COVID-19 pandemic	Blood & Cancer	31:18
Breast cancer risk with HRT, statins and colorectal cancer, and SBRT for lung metastases	Blood & Cancer	09:11
How to use antiemetics: Dr. Paul Hesketh reviews ASCO’s guidelines on antiemetic use in cancer patients receiving checkpoint inhibitors or antineoplastic agents	Blood & Cancer	25:57
Patients will gain access to clinical notes, lung cancer screening guidelines fall short, and AML standard remains elusive	Blood & Cancer	07:24
Hematology case review: Suspected ITP, presumed heparin-induced thrombocytopenia, and an ‘interesting’ case of anemia	Blood & Cancer	27:30
Choosing surgery for older breast cancer patients, delayed screening from COVID-19 could increase deaths, and blood group O linked to decreased SARS-CoV-2 risk	Blood & Cancer	10:42

Biosimilars with Dr. Gary Lyman

Blood & Cancer

32:06

Advanced bladder cancer: Dr. Arjun Balar talks treatment strategies in a changing field

Blood & Cancer

27:25

Gene therapies in hemophilia with Dr. Glenn Pierce

Blood & Cancer

24:10

Thrombosis and thrombocytopenia caused by COVID-19 vaccines: How to identify and treat VITT, VIPIT, or TTS

Blood & Cancer

23:11